Gleevec as therapy for relapsed Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) after Bone Marrow Transplantation (BMT)

Gleevec as therapy for relapsed Chronic Myeloid Leukemia (CML) and Ph+ Acute Lymphoblastic Leukemia (ALL) after Bone Marrow Transplantation (BMT)

Saved in:
Bibliographic Details
Published in:Biology of blood and marrow transplantation Vol. 12; no. 2; p. 24
Main Authors: Funke, V.M., Samir, N., Michel, O.M., Henrique, B., Nelma, C., Fernanda, L., Nelson, H., Marci, P., de Lima, D.H., Setubal, D.C., Jefferson, R., Bonfim, C.M., Bitencourt, M.A., de Medeiros, C.R., Zanis, J., Pasquini, R.
Format: Journal Article
Language:English
Published: Elsevier Inc 01-02-2006
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1083-8791
1523-6536
DOI:10.1016/j.bbmt.2005.11.074